Adam R. Craig
VP and Chief Medical Officer, CytRx Oncology Corp.
Companies
- X4 Pharmaceuticals, IncChair Aug 14, 2025 to now1
- CTI BioPharmaChief executive officer Oct 3, 2017 to Jun 26, 20232
- CTI BioPharmaPresident Oct 3, 2017 to Jun 26, 20232
- CTI BioPharmaBoard member Mar 21, 2017 to Jun 26, 20233
- CTI BioPharmaOfficer Mar 21, 2017 to Mar 21, 20173
- Viracta Therapeutics, Inc.EVP, Development & CMO Mar 2, 2012 to Mar 2, 20154
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- X4 Pharmaceuticals, Inc XFOR328,651 shares5$843.0K at $2.56Aug 12, 2026
CTI BioPharma0 shares6Jun 26, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 12, 2026Sold 47,436 shares at $4.44 of X4 Pharmaceuticals, Inc5
- Oct 23, 2025Bought 86,206 shares at $2.90 of X4 Pharmaceuticals, Inc7
- Aug 14, 2025Granted 289,881 shares of X4 Pharmaceuticals, Inc8
- Jun 26, 2023U 31,470 shares at $9.10 of CTI BioPharma6
- Jan 24, 2023Sold 2,117 shares at $6.01 of CTI BioPharma9
- Jan 24, 2023Exercised options 2,117 shares at $0.84 of CTI BioPharma9
- Jan 24, 2023Sold 83,200 shares at $6.00 of CTI BioPharma9
- Jan 24, 2023Exercised options 83,200 shares at $0.84 of CTI BioPharma9
- Jan 3, 2023Sold 84,683 shares at $6.01 of CTI BioPharma10
- Jan 3, 2023Exercised options 84,683 shares at $0.84 of CTI BioPharma10
- Dec 30, 2022Sold 4,400 shares at $6.01 of CTI BioPharma10
- Dec 30, 2022Exercised options 4,400 shares at $0.84 of CTI BioPharma10
- Dec 30, 2022Sold 700 shares at $6.01 of CTI BioPharma10
- Dec 30, 2022Exercised options 700 shares at $0.84 of CTI BioPharma10
- Dec 30, 2022Sold 12,000 shares at $6.00 of CTI BioPharma10
- Dec 30, 2022Exercised options 12,000 shares at $0.84 of CTI BioPharma10
- Dec 30, 2022Granted 1,579 shares at $5.11 of CTI BioPharma10
- Dec 29, 2022Sold 13,800 shares at $6.00 of CTI BioPharma10
- Dec 29, 2022Exercised options 13,800 shares at $0.84 of CTI BioPharma10
- Nov 10, 2022Sold 2,700 shares at $6.04 of CTI BioPharma11
- Nov 10, 2022Sold 5,800 shares at $6.03 of CTI BioPharma11
- Nov 10, 2022Sold 16,396 shares at $6.02 of CTI BioPharma11
- Nov 10, 2022Sold 100 shares at $6.02 of CTI BioPharma11
- Nov 10, 2022Sold 26,700 shares at $6.01 of CTI BioPharma11
- Nov 10, 2022Sold 200 shares at $6.01 of CTI BioPharma11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARX4 Pharmaceuticals, Inc, Chair
- 2
- 3SEC EDGARCTI BioPharma, Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Oct 27, 2025
- 8SEC EDGARForm 4 filed Aug 14, 2025
- 9SEC EDGARForm 4 filed Jan 26, 2023
- 10SEC EDGARForm 4 filed Jan 3, 2023
- 11SEC EDGARForm 4 filed Nov 14, 2022